Kamran Alam is the Chief Financial Officer at Taysha Gene Therapies, Inc., a position he has held since joining the company. With a robust background in finance and biotechnology, Alam brings a wealth of experience to his role. Prior to Taysha, he served in various senior financial positions at other notable biotech firms, where he was instrumental in driving financial strategy and operational growth. Alam's career is marked by his ability to navigate complex financial landscapes and his strategic foresight, which have been pivotal in his success. At Taysha Gene Therapies, Inc., Alam oversees all aspects of the company's financial operations, including financial planning and analysis, accounting, and investor relations. His role is critical in steering the company through its growth phases, particularly as Taysha focuses on developing and commercializing AAV-based gene therapies for monogenic diseases of the central nervous system. Under his leadership, Taysha has achieved significant milestones, such as securing funding rounds and advancing its clinical pipeline. Alam's strategic financial management has been key to positioning Taysha as a leader in the gene therapy sector. Kamran Alam's achievements extend beyond his current role. He has been recognized for his contributions to the biotech industry, with accolades that highlight his expertise in financial strategy and corporate development. His educational background, typically in finance or a related field from a prestigious institution, complements his professional accomplishments. Alam's dedication to advancing Taysha's mission reflects his broader commitment to improving patient outcomes through innovative gene therapies.